Stabilized Oxymetazoline Formulations And Their Uses

Abstract

The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Oct 31, 2017
  • Application: Jun 11, 2015
    US US 201514737360 A
  • Priority: Jun 11, 2015
    US US 201514737360 A
  • Priority: Oct 28, 2014
    US US 201462069624 P
  • Priority: Jun 11, 2014
    US US 201462010838 P

Sign in to the Lens